ARPA-H可以给纳税人更公平的待遇

IF 2.2 4区工程技术 Q3 ENGINEERING, INDUSTRIAL

Issues in Science and Technology Pub Date : 2023-07-03 DOI:10.58875/fzcy3135

T. Whitfill, M. Mazzucato

引用次数: 0

摘要

美国制药公司将纳税人资助的创新转化为天文数字的利润。一个专注于健康创新的新机构可以将医疗进步的回报转化为有益于公共健康。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

ARPA-H Could Offer Taxpayers a Fairer Shake

US drug companies turn taxpayer-funded innovation into astronomical profits. A new agency focused on health innovation could shift the rewards of medical advances to benefit public health.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Issues in Science and Technology 管理科学-工程：工业

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Issues in Science and Technology publishes articles that analyze and provide original perspectives on current topics in science and technology policy. These articles recommend actions by government, industry, academia, and individuals to solve pressing problems. The pages of Issues are open to anyone who can write an informed, well-reasoned, and policy-relevant article. We are open to a variety of authorial styles and voices, so long as articles are analytically rigorous and written for educated but nonspecialist readers.